DNMT3A mutations are considered early events in MPN evolution and, similarly to TET2 mutations, the order of acquisition affects the MPN phenotypes with a propensity for ET upon DNMT3A followed by JAK2 mutations and for PV upon acquisition of DNMT3A after JAK2 mutations [56]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.